News & Updates

New drug applications approved by US FDA as of 1-15 September 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

The long-term use of skeletal muscle relaxants (SMRs) for chronic pain is beneficial only in patients with painful spasms or cramps and neck pain but not in those with low back pain, fibromyalgia, and headaches, according to the results of a systematic review and meta-analysis.

Older nursing home residents who have been deprescribed antihypertensive medications show slower cognitive decline when compared with residents who maintain a stable antihypertensive regimen, as shown in a study.

For patients who have been placed on a nasogastric tube shortly after stroke onset, a 4-day treatment course of metoclopramide does not appear to have any effect on the incidence of pneumonia or functional outcomes, according to data from the PRECIOUS trial.